Impact of cyclin D1 and DJ-1 on diagnosis, clinico-pathological features and outcome in prostate cancer and benign prostatic hyperplasia Cover

.blurhash-client-img { display: none !important; }

Impact of cyclin D1 and DJ-1 on diagnosis, clinico-pathological features and outcome in prostate cancer and benign prostatic hyperplasia

Forum of Clinical Oncology

Volume 10 (2019): Issue 2 (December 2019)

By: Amrallah A. Mohammed, Hanna M. Ibrahim, Hanna A. Atwa, Ayman Elshentenawy and Amira Elwan

Open Access

|Apr 2020

Authors

Amrallah A. Mohammed

amrallaabdelmoneem@yahoo.com

Medical Oncology Department, Faculty of Medicine, Zagazig University, Egypt

Hanna M. Ibrahim

Department of Pathology, Faculty of Medicine, Zagazig University

Hanna A. Atwa

Department of Pathology, Faculty of Medicine, Zagazig University

Ayman Elshentenawy

Kasr EL Einy center of clinical oncology and nuclear (NEMROCK), Cairo university, Egypt

Amira Elwan

Clinical oncology Department, Faculty of Medicine, Zagazig University, Egypt

DOI: https://doi.org/10.2478/fco-2019-0005 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Page range: 15 - 25

Submitted on: Aug 3, 2018

Accepted on: Jul 21, 2019

Published on: Apr 5, 2020

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Prostate carcinoma,

benign prostatic hyperplasia,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2020 Amrallah A. Mohammed, Hanna M. Ibrahim, Hanna A. Atwa, Ayman Elshentenawy, Amira Elwan, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 10 (2019): Issue 2 (December 2019)Next article